STAAR Surgical(STAA) - 2025 Q2 - Quarterly Results

Exhibit 99.1 STAAR Surgical Reports Second Quarter 2025 Results LAKE FOREST, CA, August 6, 2025 --- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended June 27, 2025. Gross profit margin for the second quarter of 2025 was 74.0% of total net sales compared to the prior year quarter of 79.2% of total net sales and 65.8% of total net sales in the first qu ...